Published in Am J Transplant on May 28, 2008
Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation. Clin J Am Soc Nephrol (2011) 1.70
Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation. Am J Kidney Dis (2010) 1.12
Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging. Clin J Am Soc Nephrol (2009) 1.09
Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis (2009) 0.94
Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease. Clin J Am Soc Nephrol (2009) 0.93
Transplant options for patients with type 2 diabetes and chronic kidney disease. World J Transplant (2014) 0.83
Risk-stratified cardiovascular screening including angiographic and procedural outcomes of percutaneous coronary interventions in renal transplant candidates. J Transplant (2014) 0.79
Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantation. BMC Nephrol (2015) 0.77
Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome-a single-center study. Transplant Res (2014) 0.77
Prognostic Utility of Calcium Scoring as an Adjunct to Stress Myocardial Perfusion Scintigraphy in End-Stage Renal Disease. Am J Cardiol (2016) 0.76
Pretransplant cardiac evaluation: does it really prevent cardiovascular complications? Am J Transplant (2008) 0.75
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75
Screening for cardiovascular disease before kidney transplantation. World J Transplant (2015) 0.75
Functional cardiopulmonary exercise testing in potential renal transplant recipients. J Am Soc Nephrol (2013) 0.75
Diagnosis and treatment of coronary artery disease in hemodialysis patients evaluated for transplant. Transplant Res (2012) 0.75
Stress SPECT Myocardial Perfusion Imaging in End-Stage Renal Disease. Curr Cardiovasc Imaging Rep (2017) 0.75
Biochemical detection of left-ventricular systolic dysfunction. Lancet (1998) 7.51
Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J (2000) 7.48
The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med (1999) 6.13
Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat Cell Biol (1999) 4.76
Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet (1995) 4.34
What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr (1987) 4.21
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet (1997) 3.70
The stanley foundation brain collection and neuropathology consortium. Schizophr Res (2000) 3.37
Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J (1993) 3.35
The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant (2010) 3.35
Epidural analgesia: first do no harm. Anaesthesia (2008) 3.27
H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol Cell Biol (2000) 3.24
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
Serological properties of gamma-A antibodies to Escherichia coli present in human colostrum. Immunology (1966) 3.11
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2007) 3.02
Captopril in heart failure. A double blind controlled trial. Br Heart J (1984) 2.85
Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int (2006) 2.80
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J (1985) 2.74
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients. Am J Transplant (2010) 2.66
Myosin VI isoform localized to clathrin-coated vesicles with a role in clathrin-mediated endocytosis. EMBO J (2001) 2.57
Factors influencing coronary artery bypass graft patency. Cardiovasc Surg (1994) 2.39
Bronchial lymphoid tissue. I. Morphologic characteristics. Lab Invest (1973) 2.17
Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) (1985) 2.14
Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med (1986) 2.13
The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell (2000) 2.12
Coronary heart disease. BMJ (1991) 2.09
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study. Am J Transplant (2005) 2.01
Syntaxin 7 is localized to late endosome compartments, associates with Vamp 8, and Is required for late endosome-lysosome fusion. Mol Biol Cell (2000) 1.95
Randomized clinical trial of supportive follow-up for cigarette smokers in a family practice. Can Med Assoc J (1982) 1.94
Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med (1987) 1.94
A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J Cell Biol (2001) 1.92
Factors affecting the prognosis in acute renal failure. A survey of 251 cases. Q J Med (1973) 1.91
Evaluation of public health preschool child developmental screening: the process and outcomes of a community program. Am J Public Health (1987) 1.91
Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. J Am Coll Cardiol (1991) 1.82
Life-threatening arrhythmias and intravenous cimetidine. Br Med J (1979) 1.81
NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J (2006) 1.81
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart (2001) 1.77
Mortality in heart failure: clinical variables of prognostic value. Br Heart J (1987) 1.67
Isolation and molecular identification of planctomycete bacteria from postlarvae of the giant tiger prawn, Penaeus monodon. Appl Environ Microbiol (1997) 1.66
Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J (1997) 1.60
Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarction. Am J Cardiol (1991) 1.59
Objective assessment of treatment in severe angina. Br Med J (1979) 1.53
Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations. Eur Heart J (2002) 1.52
ACE inhibitors for myocardial infarction and unstable angina. Lancet (1993) 1.51
Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int (1999) 1.50
Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J (1991) 1.50
Suppression of primary RH immunization by passively-administered antibody. Experiments in volunteers. Vox Sang (1969) 1.50
Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction. J Am Coll Cardiol (1999) 1.47
Plasma endothelin in chronic heart failure. Circulation (1992) 1.47
Plasma alpha natriuretic peptide in cardiac impairment. Br Med J (Clin Res Ed) (1986) 1.44
Unique cardioprotective potential of angiotensin converting enzyme inhibitors: a hypothesis still to be tested on humans. J Hypertens (1991) 1.39
Risk stratification scores in elective open abdominal aortic aneurysm repair: are they suitable for preoperative decision making? Eur J Vasc Endovasc Surg (2012) 1.39
Non-invasive determination of cardiac output by Doppler echocardiography and electrical bioimpedance. Br Heart J (1990) 1.36
Bronchial lymphoid tissue. II. Functional characterisitics. Lab Invest (1973) 1.36
ABC of arterial and venous disease. Renal artery stenosis. BMJ (2000) 1.36
Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer. Br Heart J (1990) 1.36
Predicting nutrition-associated complications for patients undergoing gastrointestinal surgery. JPEN J Parenter Enteral Nutr (1987) 1.32
Comparison of the short-term effects of candoxatril, an orally active neutral endopeptidase inhibitor, and frusemide in the treatment of patients with chronic heart failure. Am Heart J (1999) 1.28
Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol (2008) 1.26
Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol (1992) 1.24
Gut-associated lymphoid tissue in the chicken. I. Morphology, ontogeny, and some functional characteristics of Peyer's patches. J Immunol (1980) 1.23
Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens (1990) 1.23
General practice referrals to a department of neurology. J R Coll Physicians Lond (1997) 1.22
Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. Br Heart J (1986) 1.22
NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail (2004) 1.19
Exploitation of major histocompatibility complex class I molecules and caveolae by simian virus 40. Immunol Rev (1999) 1.19
A morphologic study of rabbit bronchial lymphoid aggregates and lymphoepithelium. Lab Invest (1976) 1.17
Neuroendocrine activation after acute myocardial infarction. Br Heart J (1988) 1.16
Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J (1993) 1.14
Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells. Proc Natl Acad Sci U S A (2001) 1.13
Converting enzyme inhibitors in hypertension and heart failure. Br Heart J (1983) 1.12
Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation (1987) 1.12
Optimum conditions for cryoquenching of small tissue blocks in liquid coolants. J Microsc (1982) 1.12
Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010. Aliment Pharmacol Ther (2011) 1.10
QT dispersion before and after hemodialysis. J Am Soc Nephrol (1999) 1.10
Labetalol in resistant hypertension. Br J Clin Pharmacol (1976) 1.09
Serologic types of Pseudomonas aeruginosa based on heat-stable O antigens: correlation of Habs' (European) and Verder and Evans' (North American) classifications. J Infect Dis (1966) 1.09
Nifedipine and propranolol: a beneficial drug interaction. Am J Med (1981) 1.08
Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant (2001) 1.08
Purification and characterization of the reconstitutively active tricarboxylate transporter from rat liver mitochondria. J Biol Chem (1990) 1.07
Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic. J Hypertens (1990) 1.07
Is there autonomic impairment in congestive (dilated) cardiomyopathy? Lancet (1981) 1.06
Cardiovascular effects of training for a marathon run in unfit middle aged men. Br Med J (Clin Res Ed) (1987) 1.06
The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension (1999) 1.06
Predicting spatial patterns of eagle migration using a mesoscale atmospheric model: a case study associated with a mountain-ridge wind development. Int J Biometeorol (2013) 1.06
Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension. Br Heart J (1987) 1.06
Total body potassium in long-term frusemide therapy: is potassium supplementation necessary? Br Med J (1974) 1.04
Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies. AIDS (1998) 1.04
Effects of UK 69 578: a novel atriopeptidase inhibitor. Lancet (1989) 1.03